Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

• Váldodahkkit: M. Ávila-Núñez (Dahkki), O. Lima (Dahkki), A. Sousa (Dahkki), M. Represa (Dahkki), P. Rubiñán (Dahkki), P. Celestino (Dahkki), M. Garrido-Ventín (Dahkki), L. García-Formoso (Dahkki), F. Vasallo-Vidal (Dahkki), L. Martinez-Lamas (Dahkki), A. Pérez-Landeiro (Dahkki), M Rubianes (Dahkki), MT. Pérez-Rodríguez (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2023-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Introduction Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobact...